CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - South Africa

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - South Africa
Décembre 2014
Afrique du Sud
Type de Produit
Market Report
Description du rapport

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - South Africa”. The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in South Africa. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

The population of South Africa was approximately 53 million in 2013, having grown at a Compound Annual Growth Rate (CAGR) of 1.7% from 2008. In 2011, the government introduced the National Health Insurance (NHI) scheme, although it is still in the early stages of implementation and is not expected to be fully implemented until 2025. In 2013, the government spent $2.2 billion on R&D and exported approximately $198.1m of pharmaceuticals. The pharmaceutical market was worth approximately $2.5 billion in 2008, and is projected to reach approximately $5.6 billion by 2020 at a CAGR of 7.0%. The medical device market was valued at $1.6 billion in 2008 and is projected to grow at a CAGR of 4.1% to an estimated $2.6 billion in 2020. These positive growth trends can be primarily attributed to -

- An increasingly elderly population

- Government initiatives

- Domestic business competitiveness


The report provides information on the healthcare, regulatory, and reimbursement landscape in South Africa, and includes -

- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers

- Profiles and SWOT analyses of the major players in the pharmaceutical market: Aspen Pharmacare, Adcock Ingram, Sanofi, Pfizer and Roche; and profiles and SWOT analyses of the major players in the medical device market: Siemens Healthcare, Essilor, B. Braun, Roche, Covidien

- Insightful review of the reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices

- Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure

- An overview of the opportunities for and challenges to growth in the healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to -

- Develop business strategies by understanding the trends shaping and driving the South African healthcare market

- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to affect the South African healthcare market in the future

- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors

- Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment, and strategic partnerships

- Identify, understand, and capitalize on the opportunities and challenges in the South African healthcare market

Table des matières

1 Table of Contents

1 Table of Contents 6

1.1 List of Tables 10

1.2 List of Figures 14

2 Introduction 19

2.1 GlobalData Report Guidance 19

3 Overview of the Pharmaceutical and Medical Device Markets 20

3.1 Pharmaceutical Market 20

3.1.1 Market Overview 20

3.1.2 Pharmaceutical Exports and Imports 22

3.1.3 Supply Channels 24

3.1.4 Market Segments 26

3.1.5 Overview of Top Five Therapeutic Areas 32

3.1.6 Major Players 33

3.2 Medical Device Market 75

3.2.1 Market Overview 75

3.2.2 Overview of Top Five Segments 77

3.2.3 Diagnostic Market 91

3.2.4 Major Players 93

3.3 Market Drivers and Barriers 122

3.3.1 Drivers 122

3.3.2 Barriers 123

4 Market Access 125

4.1 Reimbursement and Payer Landscape 125

4.1.1 Overview of Healthcare System 125

4.1.2 Reimbursement Process 128

4.1.3 Overview of Insurance Providers 131

4.1.4 Patient Share in Healthcare Spending 133

4.1.5 Pricing Policies 134

4.2 Regulatory Landscape 135

4.2.1 Overview of Regulatory Agencies 135

4.2.2 Market Authorization Procedure for Medicines 137

4.2.3 Market Authorization Procedure for Medical Devices 141

4.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 143

4.2.5 Licensing Process for Pharmaceutical Exports and Imports 144

4.2.6 Intellectual Property Rights 147

4.2.7 Clinical Trial Regulations 152

4.2.8 Pharmaceutical Advertising Regulations 155

4.2.9 Pharmacy Regulations 156

4.2.10 Labeling and Packaging Regulations 158

5 Country Analysis 163

5.1 Political Environment 163

5.1.1 Political Structure 163

5.1.2 Analysis of the Current Political Environment 164

5.1.3 Healthcare Policy Initiatives 167

5.2 Economic Landscape 167

5.3 Economic Indicators 171

5.3.1 Gross Domestic Product 171

5.3.2 Gross National Income 176

5.3.3 Inflation 177

5.3.4 Currency Exchange Rate 180

5.3.5 Foreign Direct Investment 181

5.3.6 Foreign Exchange Reserves 182

5.3.7 Trade Balance 183

5.3.8 General Government Structural Balance 186

5.3.9 General Government Net Debt 188

5.3.10 Major Industries 190

5.4 Demographics 191

5.4.1 Population 191

5.4.2 Education and Literacy 210

5.4.3 Employment 214

5.4.4 Disease Burden 216

5.5 Healthcare Infrastructure 219

5.5.1 Healthcare Facilities 219

5.5.2 Healthcare Parameters 225

5.5.3 Environmental Health 230

5.5.4 Healthcare Personnel 233

5.6 Healthcare Expenditure 237

5.6.1 Overview 237

5.6.2 Major Components of Healthcare Spending 238

5.6.3 Public and Private Sector Share 239

5.6.4 Spending in Healthcare, Research and Development 241

5.7 Trade Associations 244

5.7.1 Innovative Pharmaceutical Association South Africa 244

5.7.2 Pharmaceutical Society of South Africa 244

5.7.3 National Association of Pharmaceutical Manufacturers 245

5.7.4 Hospitals Association of South Africa 245

5.8 Trade Fairs 246

6 Opportunities and Challenges 247

6.1 Opportunities 247

6.2 Challenges 248

7 Appendix 250

7.1 Abbreviations 250

7.2 Bibliography 253

7.3 Research Methodology 269

7.3.1 Coverage 269

7.3.2 Secondary Research 270

7.3.3 Forecasts 270

7.3.4 Expert Panel 270

7.4 Disclaimer 271

Description de l'éditeur

GlobalData is the premier source of actionable insight into the healthcare industry. With the combined expertise of more than 1,000 researchers, market analysts and consultants, we provide high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

Combining precision with innovation, our research and consulting solutions ensure our clients stay at the forefront of their markets by integrating accurate market forecasts and analysis on the latest trends and developments with the unrivalled expertise of our analyst teams. Among other benefits, our informed industry perspectives help clients understand how to generate the maximum return from their key markets, identify opportunities from emerging trends, and devise strategies for growth with confidence.


Contact:  Partner Supportpartnersupport@globaldata.com

                 Sunil Sethia ssethia@globaldata.com